Dr. Charles Geyer discusses the KATHERINE Trial with Dr. Jame Abraham NSABP Foundation / Thursday, February 28, 2019 0 125 In this MDEdge Blood and Cancer podcast, Dr. Chuck Geyer of VCU Massey Cancer Center discusses the KATHERINE trial and breast cancer with guest host Dr. Jame Abraham of the Cleveland Clinic. Read more
Dr. Charles Geyer discusses the NSABP B-59/GBG 96-GeparDouze trial Dr. Charles Geyer discusses the NSABP B-59/GBG 96-GeparDouze trial Charles Geyer, MD, Associate Director of Clinical Research at the VCU Massey Cancer Center NSABP Foundation / Tuesday, July 31, 2018 0 1523 Charles Geyer, MD, Associate Director of Clinical Research at the Virginia Commonwealth University Massey Cancer Center and NSABP Principal Investigator discusses immunotherapy and checkpoint inhibitors for breast cancer studies including the NSABP B-59/GBG 96-GeparDouze clinical trial. Read more
Peter Lucas, MD, discusses the use of correlative science post-clinical trials Peter Lucas, MD, discusses the use of correlative science post-clinical trials Peter Lucas, MD, Associate Professor of Pathology at the University of Pittsburgh and Director of Pathology at NSABP Foundation NSABP Foundation / Thursday, July 5, 2018 0 780 Peter Lucas, MD, Associate Professor of Pathology at the University of Pittsburgh and Director of Pathology and Principal Investigator at NSABP Foundation discusses the use of correlative science post-clinical trial and why clinical trials are important. (Interviewed October 2017 at the NSABP Foundation Annual Meeting in Chicago, IL.) Read more
Jame Abraham, MD, discusses the importance of patient participation in clinical trials Jame Abraham, MD, discusses the importance of patient participation in clinical trials By Dr. Jame Abraham, Director, Breast Oncology Program, Taussig Cancer Institute, Cleveland Clinic NSABP Foundation / Friday, April 20, 2018 0 4636 Jame Abraham, MD, Director of the Breast Oncology Program at the Taussig Cancer Institute, Cleveland Clinic and a Principal Investigator with NSABP Foundation discusses his relationship with NSABP and the importance of patient participation in clinical trials research. (Interviewed October 2017 at the NSABP Foundation Annual Meeting in Chicago, IL.) Read more
Exploring the Great Unknown with Dr. Tatjana Kolevska Exploring the Great Unknown with Dr. Tatjana Kolevska Tatjana Kolevska, MD, Associate Director, Kaiser Permanente Oncology Clinical Trials Program NSABP Foundation / Tuesday, March 27, 2018 0 1159 Pushing the boundaries of science and knowledge both intrigue and motivate Dr. Tatjana Kolevska. Discovering “the great unknown” is a concept that appeals to her, and she says that if she did not practice medicine, she would love to be a space explorer. Read more